Water extracts of Tibetan medicine Wuweiganlu attenuates experimental arthritis via inducing macrophage polarization towards the M2 type.

[1]  Zhuoma Garang,et al.  Commiphora mukul (Hook. ex Stocks) Engl.: Historical records, application rules, phytochemistry, pharmacology, clinical research, and adverse reaction. , 2023, Journal of ethnopharmacology.

[2]  K. Liao,et al.  Shared inflammatory pathways of rheumatoid arthritis and atherosclerotic cardiovascular disease , 2023, Nature Reviews Rheumatology.

[3]  Sanyin Zhang,et al.  Integrating UPLC-Q-Exactive Orbitrap/MS, network pharmacology and experimental validation to reveal the potential mechanism of Tibetan medicine Rhodiola granules in improving myocardial ischemia-reperfusion injury. , 2023, Journal of ethnopharmacology.

[4]  Anhua Wang,et al.  An integrated network pharmacology approach reveals that Darutigenol reduces inflammation and cartilage degradation in a mouse collagen-induced arthritis model by inhibiting the JAK-STAT3 pathway. , 2023, Journal of ethnopharmacology.

[5]  Jinsong Su,et al.  Tibetan medicine Qi-Sai-Er-Sang-Dang-Song Decoction inhibits TNF-α-induced rheumatoid arthritis in human fibroblast-like synoviocytes via regulating NOTCH1/NF-κB/NLRP3 pathway. , 2023, Journal of ethnopharmacology.

[6]  G. Firestein,et al.  The pathogenesis of rheumatoid arthritis. , 2022, Immunity.

[7]  D. Veale,et al.  Rheumatoid arthritis macrophages are primed for inflammation and display bioenergetic and functional alterations , 2022, Rheumatology.

[8]  Yao Huang,et al.  Wutou decoction attenuates the synovial inflammation of collagen-induced arthritis rats via regulating macrophage M1/M2 type polarization. , 2022, Journal of ethnopharmacology.

[9]  Ranjeny Thomas,et al.  Global epidemiology of rheumatoid arthritis , 2022, Nature Reviews Rheumatology.

[10]  U. Göransson,et al.  Where traditional Chinese medicine meets Western medicine in the prevention of rheumatoid arthritis , 2022, Journal of internal medicine.

[11]  N. Ganguly,et al.  Rheumatoid arthritis: advances in treatment strategies , 2022, Molecular and Cellular Biochemistry.

[12]  John J. Cush.  Rheumatoid Arthritis: Early Diagnosis and Treatment. , 2022, Rheumatic diseases clinics of North America.

[13]  C. Redshaw,et al.  Network Pharmacology and Molecular Docking Study of the Chinese Miao Medicine Sidaxue in the Treatment of Rheumatoid Arthritis , 2022, Drug design, development and therapy.

[14]  D. Brand,et al.  Collagen‐Induced Arthritis Mouse Model , 2021, Current protocols.

[15]  Chunhong Li,et al.  M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Hu-dan Pan,et al.  Elucidation of the Anti-inflammatory Mechanism of Er Miao San by Integrative Approach of Network Pharmacology and Experimental Verification , 2021, Pharmacological Research.

[17]  K. Garcia,et al.  Cryo‐EM structure of the IL‐10 receptor complex provides a blueprint for ligand engineering , 2021, The FEBS journal.

[18]  A. Devitt,et al.  Macrophages: The Good, the Bad, and the Gluttony , 2021, Frontiers in Immunology.

[19]  C. Fu,et al.  Integrated serum pharmacochemistry and network pharmacological analysis used to explore possible anti-rheumatoid arthritis mechanisms of the Shentong-Zhuyu Decoction. , 2021, Journal of ethnopharmacology.

[20]  M. Cutolo,et al.  Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review. , 2019, Autoimmunity reviews.

[21]  N. Cirillo,et al.  Prognostic significance of CD68+ and CD163+ tumor associated macrophages in head and neck squamous cell carcinoma: A systematic review and meta-analysis. , 2019, Oral oncology.

[22]  Wanli W. Smith,et al.  M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds , 2019, International immunopharmacology.

[23]  Surovi Saikia,et al.  Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective. , 2019, Current drug targets.

[24]  Y. Degboé,et al.  Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism , 2019, Front. Immunol..

[25]  M. Cutolo,et al.  Monocyte and macrophage phenotypes: a look beyond systemic sclerosis. Response to: 'M1/M2 polarisation state of M-CSF blood-derived macrophages in systemic sclerosis' by Lescoat et al , 2018, Annals of the rheumatic diseases.

[26]  M. Cutolo,et al.  A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement , 2018, Respiratory Research.

[27]  R. Z. Murray,et al.  Macrophage Phenotypes Regulate Scar Formation and Chronic Wound Healing , 2017, International journal of molecular sciences.

[28]  F. Díaz-González,et al.  Role of physical activity in the management and assessment of rheumatoid arthritis patients. , 2017, Reumatologia clinica.

[29]  I. McInnes,et al.  Rheumatoid arthritis , 2016, The Lancet.

[30]  W. Liu,et al.  A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Tong Luo Hua Shi capsule, a modernized Tibetan medicine, in patients with rheumatoid arthritis , 2016, Trials.

[31]  T. Huizinga,et al.  Drivers of costly treatment strategies in rheumatoid arthritis , 2016, The Lancet.

[32]  A. Mauro,et al.  M1 and M2 macrophage recruitment during tendon regeneration induced by amniotic epithelial cell allotransplantation in ovine. , 2016, Research in veterinary science.

[33]  J. Baker,et al.  The Obesity Epidemic and Consequences for Rheumatoid Arthritis Care , 2016, Current Rheumatology Reports.

[34]  O. Silvennoinen,et al.  The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels. , 2015, Rheumatology.

[35]  J. O'dell,et al.  Combination conventional DMARDs compared to biologicals: what is the evidence? , 2015, Current opinion in rheumatology.

[36]  Yihong Yao,et al.  Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. , 2014, Pharmacology & therapeutics.

[37]  L. Ivashkiv.  Epigenetic regulation of macrophage polarization and function. , 2013, Trends in immunology.

[38]  T. Therneau,et al.  The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. , 2011, Arthritis and rheumatism.

[39]  A. Barton,et al.  Genetic susceptibility to rheumatoid arthritis: an emerging picture. , 2009, Arthritis and rheumatism.

[40]  E. Buzás,et al.  Rheumatoid arthritis and smoking: putting the pieces together , 2009, Arthritis research & therapy.

[41]  A. Barton,et al.  Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study , 2009, Annals of the rheumatic diseases.

[42]  Wendy Thomson,et al.  Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[43]  T. Huizinga,et al.  Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets , 2008, Arthritis research & therapy.

[44]  D. Felson.  Comparing the prevalence of rheumatic diseases in China with the rest of the world , 2008, Arthritis research & therapy.

[45]  S. Ansar Ahmed,et al.  Effects of short-term administration of sex hormones on normal and autoimmune mice. , 1985, Journal of immunology.

[46]  J. Alvarez-Nemegyei,et al.  Association between Overweight/Obesity and Clinical Activity in Rheumatoid Arthritis. , 2020, Reumatologia clinica.

[47]  Shuang Liu,et al.  Collagen-Induced Arthritis Models. , 2018, Methods in molecular biology.

[48]  M. Feldmann,et al.  Rheumatoid Arthritis , 1996, Cell.